Sharekhan

BUY NOW Buy Praveg Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Praveg Ltd

Wed 30/04/2025,16:1:0

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Praveg Ltd

Your Vote -

Buy

50.00%

Hold

31.25%

Sell

18.75%

50.00%

32 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Praveg Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Praveg L - Announcement under Regulation 30 (LODR)-Scheme of Arrangement

    23 Apr 2025, 8:57PM Disclosure under Regulation 30 of SEBI Listing Regulations, the Board considered and approved the draft Scheme of Amalgamation between Eulogia Inn Pri

  • Praveg L - Board Meeting Outcome for Revised Outcome Of Board Meeting Held Today

    23 Apr 2025, 8:55PM Revised outcome of Board Meeting held on April 23, 2025

  • Praveg L - Announcement under Regulation 30 (LODR)-Scheme of Arrangement

    23 Apr 2025, 8:29PM The Board of Directors considered and approved, in their meeting held today i.e. April 23, 2025, the draft scheme of amalgamation between Eulogia Inn

  • Praveg L - Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday, April 23, 2025

    23 Apr 2025, 8:24PM In continuation of our intimation dated April 19, 2025 and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Re

  • Praveg L - Board Meeting Intimation for Consideration And Approval Scheme Of Amalgamation

    19 Apr 2025, 7:10PM Praveg Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/04/2025 ,inter alia, to consider and approve t

  • Praveg L has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    18 Apr 2025, 8:10PM As of March 2025, 45.50% is owned by Indian Promoters and 54.50% by Public. <p align=justify> Institutional holds 14.78% (Insurance Companies 1.96%) a

  • Praveg L - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    4 Apr 2025, 1:58PM Pursuant to Regulation 74(5) of the SEBI (DP) Regulations, 2018, please find enclosed a copy of the certificate for the quarter ended March 31, 2025 a

  • Praveg L - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    2 Apr 2025, 5:19PM Postal Ballot Notice dated March 29, 2025 (\the Notice\) together with the Explanatory Statement seeking approval of the members of the company, by wa

  • Praveg L - Announcement under Regulation 30 (LODR)-Change in Management

    29 Mar 2025, 4:56PM This is to inform you that the Board of Directors of the Company in their meeting held today i.e. March 29, 2025, inter alia, have considered and appr

  • Praveg L - Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. March 29, 2025

    29 Mar 2025, 4:49PM Disclosure under Regulation 30 and other applicable regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listi

  • Praveg L - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    26 Mar 2025, 3:55PM Outcome of Analyst / Investors Meeting

  • Praveg L - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    3 Mar 2025, 11:46AM We are pleased to inform you that company has entered into Hotel Management Agreement with the Indian Hotels Company Limited for proposed hotel Banga

  • Praveg L - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    28 Feb 2025, 6:13PM Outcome of the Analyst / Investor Meet dated February 28, 2025

  • Praveg L has submitted to BSE the Shareholding Pattern for the Period Ended February 13, 2025

    23 Feb 2025, 5:00PM As of February 2025, 45.42% is owned by Indian Promoters and 54.58% by Public. <p align=justify> Institutional holds 15.58% (Insurance Companies 1.96%

  • Praveg L - Announcement under Regulation 30 (LODR)-Scheme of Arrangement

    22 Feb 2025, 4:59PM In continuation of our intimation dated October 26, 2023, please find attached update on Scheme of Amalgamation of Eulogia Inn Private Limited with Pr

  • Praveg L - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    21 Feb 2025, 7:21PM Outcome of Investor/ Analyst meet with the officials of Relax Capital wherein no UPSI was shared

  • Praveg L - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    18 Feb 2025, 8:38PM Intimation of Investor Meet to be held on Friday, February 21, 2025

  • Praveg L - Non-Exercise Of Conversion Of Convertible Warrants

    13 Feb 2025, 8:16PM The Warrantholder did not exercise the conversion option of pending 184942 warrants, which stands forfeited as per provisions of Regulation 169(3) of

  • Praveg L - Announcement under Regulation 30 (LODR)-Allotment

    13 Feb 2025, 8:06PM Allotment of equity shares pursuant to exercise of warrants allotted on preferential basis

  • Praveg L - Announcement under Regulation 30 (LODR)-Investor Presentation

    13 Feb 2025, 6:23PM Investor Presentation on Unaudited Financial Results for the quarter and nine months ended December 31, 2024

  • Praveg L - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    13 Feb 2025, 6:16PM Scrutinizer's Report for Postal Ballot through e-voting

  • Praveg L - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

    13 Feb 2025, 6:15PM Outcome of Postal Ballot through e-voting

  • Praveg L - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

    12 Feb 2025, 11:41AM Monitoring Agency Report for quarter ended December 31, 2024 issued by CRISIL Ratings Limited in relation to preferential issue of equity shares and w

  • Praveg L - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    11 Feb 2025, 5:05PM This is in continuation to our earlier letter today dated February 11, 2025 wherein the Consolidated and Standalone Unaudited Financial Results of the

  • Praveg L - Statement On Deviation Or Variation Under Regulation 32 Of The SEBI (LODR) Regulations, 2015

    11 Feb 2025, 4:56PM Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, We attached statement on deviation or varia

  • Praveg L - Integrated Filing (Financial)

    11 Feb 2025, 2:59PM Integrated Filing (Financials) is attached herewith

  • Praveg L - Grant Of Options To Eligible Employees As Per Praveg's ESOP Plan, 2024

    11 Feb 2025, 2:42PM The Board has, on recommendation of Compensation Committee, considered and approved grant of 3969 options to eligible employees as per Praveg's Plan,

  • Praveg L Q3 net profit down 5.56% at Rs 7.64 cr

    11 Feb 2025, 2:40PM The company reported standalone net profit of Rs 7.64 crore for the quarter ended December 31, 2024 as compared to Rs 8.09 crore in the same period la

  • Praveg L - Unaudited Consolidated And Standalone Financial Results For The Quarter Ended December 31, 2024

    11 Feb 2025, 2:34PM Unaudited Consolidated and Standalone Financial Results for the quarter ended December 31, 2024 along with Limited Review Report are attached herewith

  • Praveg L - Board Meeting Outcome for Outcome Of Board Meeting Held On February 11, 2025

    11 Feb 2025, 2:30PM Outcome of Board Meeting held on February 11, 2025 to consider and approve unaudited Consolidated and Standalone Financial Results for the quarter end

  • Praveg L - Grant Of Options To Eligible Employees As Per Praveg's ESOP Plan, 2024

    11 Feb 2025, 2:42PM The Board has, on recommendation of Compensation Committee, considered and approved grant of 3969 options to eligible employees as per Praveg's Plan,

  • Praveg L - Grant Of Options To Eligible Employees As Per Praveg's ESOP Plan, 2024

    11 Feb 2025, 2:42PM The Board has, on recommendation of Compensation Committee, considered and approved grant of 3969 options to eligible employees as per Praveg's Plan,

  • Praveg L - Grant Of Options To Eligible Employees As Per Praveg's ESOP Plan, 2024

    11 Feb 2025, 2:42PM The Board has, on recommendation of Compensation Committee, considered and approved grant of 3969 options to eligible employees as per Praveg's Plan,

  • Praveg L - Grant Of Options To Eligible Employees As Per Praveg's ESOP Plan, 2024

    11 Feb 2025, 2:42PM The Board has, on recommendation of Compensation Committee, considered and approved grant of 3969 options to eligible employees as per Praveg's Plan,

  • Praveg L - Grant Of Options To Eligible Employees As Per Praveg's ESOP Plan, 2024

    11 Feb 2025, 2:42PM The Board has, on recommendation of Compensation Committee, considered and approved grant of 3969 options to eligible employees as per Praveg's Plan,

  • Praveg L - Board Meeting Intimation for Approval And Consideration Of Unaudited Financial Results For The Quarter Ended Decem

    3 Feb 2025, 7:12PM Praveg Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2025 ,inter alia, to consider and approve t

  • Praveg announces Hotel Management agreement with the Indian Hotels

    3 Mar 2025 , 3:21PM Praveg inks Hotel Management agreement with IHCL for Lakshadweep resort
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Praveg Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 287.7886 112.8745 30.9841 20.043 15.8414
Liabilities 287.7886 112.8745 30.9841 20.043 15.8414
Equity 24.5326 20.9221 18.4841 18.4841 18.4841
Gross Profit 29.0812 44.8642 19.7012 15.8718 6.3624
Net Profit 12.8935 28.3802 12.2278 10.7989 3.6445
Cash From Operating Activities 16.9163 25.2123 6.5971 14.1913 2.5561
NPM(%) 14.1 33.63 27.17 23.85 6.12
Revenue 91.4175 84.3792 44.9886 45.2705 59.5179
Expenses 62.3363 39.515 25.2874 29.3987 53.1555
ROE(%) 2.93 6.46 2.78 2.46 0.83

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Praveg Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 824.20 -1.99 11.65 314.27 1321.50 1.39
Lotus Eye Hospital and Institute Ltd 80.41 -0.74 338.42 1145.15 14.01 0.62
Bharat Immunological and Biologicals Corporation Ltd 23.00 -1.41 0.00 2377.71 -39.50 0.00
Astec Lifesciences Ltd 681.00 -1.58 0.00 1079.78 -687.11 0.00

Company Info

Sword and Shield Pharma Ltd was incorporated as a Public Limited company on 28th February, 1995 with the Registrar of Companies, Gujarat State, Ahmedabad and obtained Certificate of Commencement of Business on 7th March, 1995. The Copmany was promoted by experienced entrepreneurs with a proven track record of marketing of different pharmaceuucal formulations. The Company has proposed the project at the cost of Rs.515.00 Lacs for manufacturing and marketing of different pharmaceutical formulations. The Company has started the implementation of the project by acquisition of land, admeasuring 3650 sq. yards, at village Indrad, Dist. Kadi, Gujarat. The N.A. Approval for the land is already obtained by the Company. The necessary application to Gujarat Electricity Board and Gujarat Pollution Board are already being made. 2020 -Company name has changed to Praveg Communications (India) Ltd. from Sword & Shield Pharma Ltd.. 2021 -Company Has Been Recognized As The Runner Up In The Category Of Best Eco Resort In Gujarat At Gujarat Travel & Tourism Excellence Award 2021. 2023 -Company name changed to Praveg Ltd. from Praveg Communications (India) Ltd..

Sword and Shield Pharma Ltd was incorporated as a Public Limited company on 28th February, 1995 with the Registrar of Companies, Gujarat State, Ahmedabad and obtained Certificate of Commencement of Business on 7th March, 1995. The Copmany was promoted by experienced entrepreneurs with a proven track record of marketing of different pharmaceuucal formulations. The Company has proposed the project at the cost of Rs.515.00 Lacs for manufacturing and marketing of different pharmaceutical formulations. The Company has started the implementation of the project by acquisition of land, admeasuring 3650 sq. yards, at village Indrad, Dist. Kadi, Gujarat. The N.A. Approval for the land is already obtained by the Company. The necessary application to Gujarat Electricity Board and Gujarat Pollution Board are already being made. 2020 -Company name has changed to Praveg Communications (India) Ltd. from Sword & Shield Pharma Ltd.. 2021 -Company Has Been Recognized As The Runner Up In The Category Of Best Eco Resort In Gujarat At Gujarat Travel & Tourism Excellence Award 2021. 2023 -Company name changed to Praveg Ltd. from Praveg Communications (India) Ltd..

Read More

Parent Organisation

Praveg Ltd.

Founded

28/02/1995

Managing Director

NSE Symbol

FAQ

The current price of Praveg Ltd is

The 52-week high for Praveg Ltd is

The market capitalization of Praveg Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Praveg Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Praveg Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Praveg Ltd shares.

The CEO of Praveg Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT